| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| In Situ Hybridization, Fluorescence | 36 | 2023 | 2232 | 3.230 |
Why?
|
| Biopsy, Needle | 67 | 2003 | 1363 | 1.580 |
Why?
|
| Biopsy, Fine-Needle | 15 | 2021 | 690 | 1.320 |
Why?
|
| Cytodiagnosis | 18 | 2023 | 220 | 1.300 |
Why?
|
| DNA, Neoplasm | 24 | 2008 | 1910 | 1.090 |
Why?
|
| Urinary Bladder Neoplasms | 16 | 2015 | 2341 | 0.990 |
Why?
|
| Chromosome Aberrations | 13 | 2008 | 1960 | 0.950 |
Why?
|
| Image Cytometry | 7 | 2008 | 47 | 0.930 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 17 | 2021 | 5319 | 0.930 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2021 | 607 | 0.930 |
Why?
|
| Lung Neoplasms | 25 | 2021 | 11538 | 0.920 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2010 | 311 | 0.880 |
Why?
|
| Lymphoma, Non-Hodgkin | 21 | 2005 | 1039 | 0.850 |
Why?
|
| Vaginal Smears | 5 | 2008 | 192 | 0.720 |
Why?
|
| Chromosomes, Human, Pair 11 | 5 | 2008 | 402 | 0.690 |
Why?
|
| Lymphoma, Mantle-Cell | 8 | 2010 | 713 | 0.680 |
Why?
|
| Biomarkers, Tumor | 21 | 2021 | 10331 | 0.660 |
Why?
|
| Immunophenotyping | 16 | 2006 | 1681 | 0.630 |
Why?
|
| Lymphoma, Follicular | 8 | 2006 | 587 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 14 | 5 | 2005 | 272 | 0.550 |
Why?
|
| Carcinoma, Squamous Cell | 12 | 2020 | 5437 | 0.540 |
Why?
|
| Lymphoma | 17 | 2013 | 1467 | 0.530 |
Why?
|
| Carcinoma, Transitional Cell | 10 | 2011 | 962 | 0.530 |
Why?
|
| Aneuploidy | 9 | 2020 | 369 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2010 | 135 | 0.520 |
Why?
|
| Lung Diseases | 2 | 2020 | 717 | 0.510 |
Why?
|
| Flow Cytometry | 28 | 2009 | 3033 | 0.510 |
Why?
|
| Centrosome | 2 | 2005 | 95 | 0.490 |
Why?
|
| Immunohistochemistry | 32 | 2021 | 7548 | 0.460 |
Why?
|
| Sensitivity and Specificity | 15 | 2021 | 4971 | 0.440 |
Why?
|
| Ploidies | 14 | 2005 | 248 | 0.440 |
Why?
|
| Translocation, Genetic | 7 | 2005 | 1245 | 0.440 |
Why?
|
| Cytological Techniques | 5 | 2004 | 74 | 0.440 |
Why?
|
| Pathology | 3 | 2007 | 101 | 0.440 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 7 | 2006 | 1664 | 0.430 |
Why?
|
| Sputum | 6 | 2010 | 141 | 0.430 |
Why?
|
| Interphase | 8 | 2005 | 145 | 0.420 |
Why?
|
| Neoplasm Staging | 20 | 2020 | 13658 | 0.410 |
Why?
|
| Humans | 191 | 2023 | 261506 | 0.410 |
Why?
|
| Transcription Factor AP-2 | 1 | 2011 | 79 | 0.400 |
Why?
|
| Aged | 80 | 2021 | 70117 | 0.390 |
Why?
|
| Middle Aged | 96 | 2021 | 86204 | 0.390 |
Why?
|
| Iodine Radioisotopes | 3 | 2010 | 371 | 0.380 |
Why?
|
| Carcinoma | 13 | 2005 | 2578 | 0.370 |
Why?
|
| Papanicolaou Test | 2 | 2006 | 141 | 0.360 |
Why?
|
| Hyperthyroidism | 1 | 2010 | 52 | 0.360 |
Why?
|
| Lymphocytes | 5 | 2004 | 1234 | 0.360 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2008 | 2390 | 0.360 |
Why?
|
| Urothelium | 2 | 2010 | 254 | 0.350 |
Why?
|
| Male | 93 | 2021 | 123000 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2001 | 1648 | 0.350 |
Why?
|
| Diagnosis, Differential | 18 | 2020 | 4744 | 0.340 |
Why?
|
| Thyroid Nodule | 1 | 2010 | 92 | 0.340 |
Why?
|
| Prognosis | 26 | 2021 | 21713 | 0.340 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 103 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 18 | 4 | 2003 | 181 | 0.330 |
Why?
|
| Female | 105 | 2021 | 141928 | 0.330 |
Why?
|
| S-Phase Kinase-Associated Proteins | 2 | 2005 | 51 | 0.320 |
Why?
|
| Vision, Low | 1 | 2008 | 18 | 0.320 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2008 | 36 | 0.320 |
Why?
|
| Cell Biology | 2 | 2007 | 16 | 0.310 |
Why?
|
| Specimen Handling | 3 | 2013 | 299 | 0.310 |
Why?
|
| Uterine Cervical Neoplasms | 7 | 2008 | 1833 | 0.310 |
Why?
|
| Lymph Nodes | 13 | 2023 | 2967 | 0.310 |
Why?
|
| Cell Nucleus | 10 | 2013 | 1620 | 0.300 |
Why?
|
| Hodgkin Disease | 6 | 2007 | 1429 | 0.300 |
Why?
|
| Urinary Diversion | 1 | 2007 | 69 | 0.300 |
Why?
|
| Thalamus | 1 | 2008 | 132 | 0.300 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 2 | 2010 | 13 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2020 | 7551 | 0.290 |
Why?
|
| Vaginal Neoplasms | 1 | 2008 | 152 | 0.290 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2008 | 142 | 0.290 |
Why?
|
| Isoenzymes | 1 | 2009 | 614 | 0.290 |
Why?
|
| Lymphatic Diseases | 4 | 1997 | 128 | 0.290 |
Why?
|
| Lymphoma, B-Cell | 5 | 2006 | 895 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2011 | 2359 | 0.280 |
Why?
|
| Predictive Value of Tests | 15 | 2021 | 4892 | 0.280 |
Why?
|
| Ki-67 Antigen | 6 | 2013 | 666 | 0.280 |
Why?
|
| Fruiting Bodies, Fungal | 1 | 2006 | 3 | 0.280 |
Why?
|
| Paecilomyces | 1 | 2006 | 8 | 0.280 |
Why?
|
| Breast Neoplasms | 20 | 2014 | 15694 | 0.270 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 95 | 0.270 |
Why?
|
| Astrocytoma | 1 | 2008 | 321 | 0.270 |
Why?
|
| Gene Deletion | 4 | 2009 | 1442 | 0.260 |
Why?
|
| Chromosome Deletion | 2 | 2008 | 1005 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2015 | 10035 | 0.250 |
Why?
|
| Adult | 70 | 2021 | 77950 | 0.250 |
Why?
|
| Adenocarcinoma | 16 | 2020 | 7789 | 0.240 |
Why?
|
| Mitotic Index | 2 | 2004 | 162 | 0.240 |
Why?
|
| Chromosome Breakage | 2 | 2003 | 226 | 0.230 |
Why?
|
| Cytoplasm | 5 | 2013 | 652 | 0.230 |
Why?
|
| Cell Division | 11 | 2004 | 2489 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 172 | 0.220 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1443 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2003 | 179 | 0.210 |
Why?
|
| Gene Dosage | 2 | 2006 | 829 | 0.210 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 129 | 0.210 |
Why?
|
| Ki-1 Antigen | 1 | 2003 | 182 | 0.210 |
Why?
|
| Epithelial Cells | 4 | 2008 | 1818 | 0.210 |
Why?
|
| Mycoses | 1 | 2006 | 386 | 0.210 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 155 | 0.210 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 716 | 0.210 |
Why?
|
| BCG Vaccine | 3 | 2015 | 399 | 0.210 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2013 | 1216 | 0.200 |
Why?
|
| Aged, 80 and over | 29 | 2021 | 29902 | 0.200 |
Why?
|
| Urine | 4 | 2005 | 143 | 0.200 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2002 | 247 | 0.200 |
Why?
|
| Gene Rearrangement | 3 | 2002 | 783 | 0.200 |
Why?
|
| Karyotyping | 10 | 2003 | 1022 | 0.200 |
Why?
|
| Carcinoma, Papillary | 2 | 1999 | 584 | 0.200 |
Why?
|
| Mediastinal Neoplasms | 3 | 1998 | 423 | 0.190 |
Why?
|
| Chromosome Fragility | 1 | 2000 | 33 | 0.190 |
Why?
|
| RNA Interference | 1 | 2005 | 1408 | 0.190 |
Why?
|
| Gene Expression Profiling | 9 | 2013 | 5159 | 0.190 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 90 | 0.180 |
Why?
|
| A549 Cells | 1 | 2020 | 124 | 0.180 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 158 | 0.170 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2003 | 387 | 0.170 |
Why?
|
| Bronchi | 3 | 2011 | 326 | 0.170 |
Why?
|
| Parotid Diseases | 1 | 1998 | 12 | 0.170 |
Why?
|
| Urinary Bladder | 3 | 2005 | 575 | 0.160 |
Why?
|
| Oncogenes | 5 | 2011 | 673 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 11 | 2011 | 5395 | 0.160 |
Why?
|
| DNA | 4 | 2005 | 2693 | 0.160 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 6009 | 0.160 |
Why?
|
| Neoplasms | 8 | 2023 | 15193 | 0.160 |
Why?
|
| Parotid Neoplasms | 1 | 1998 | 148 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 8873 | 0.150 |
Why?
|
| Staining and Labeling | 5 | 2005 | 429 | 0.150 |
Why?
|
| Receptors, Estrogen | 4 | 2013 | 2086 | 0.150 |
Why?
|
| Pathology, Surgical | 1 | 1997 | 81 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 1999 | 355 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2014 | 6207 | 0.150 |
Why?
|
| Ascitic Fluid | 4 | 1996 | 76 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 2508 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 986 | 0.140 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 4821 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2021 | 2326 | 0.140 |
Why?
|
| MicroRNAs | 3 | 2020 | 2947 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 1493 | 0.140 |
Why?
|
| Neutrophils | 1 | 2021 | 835 | 0.140 |
Why?
|
| Diagnostic Errors | 4 | 1997 | 509 | 0.140 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 602 | 0.140 |
Why?
|
| Thyroid Neoplasms | 4 | 1999 | 1866 | 0.140 |
Why?
|
| Transcription Factors | 4 | 2013 | 5270 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 8 | 2011 | 1165 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 1242 | 0.130 |
Why?
|
| Pericardial Effusion | 2 | 1994 | 118 | 0.130 |
Why?
|
| Urogenital Neoplasms | 1 | 1996 | 108 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 5 | 2013 | 2518 | 0.130 |
Why?
|
| Papillomaviridae | 4 | 2013 | 624 | 0.130 |
Why?
|
| Thymoma | 1 | 1998 | 246 | 0.130 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 1258 | 0.120 |
Why?
|
| Follow-Up Studies | 9 | 2011 | 14889 | 0.120 |
Why?
|
| ErbB Receptors | 4 | 2020 | 2295 | 0.120 |
Why?
|
| Adenoma | 3 | 2010 | 716 | 0.120 |
Why?
|
| Cystectomy | 4 | 2011 | 623 | 0.120 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 1997 | 551 | 0.120 |
Why?
|
| Adenoma, Islet Cell | 1 | 1994 | 27 | 0.120 |
Why?
|
| Neoplasm Metastasis | 7 | 2008 | 5112 | 0.120 |
Why?
|
| Biopsy | 6 | 2002 | 3443 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2011 | 7226 | 0.120 |
Why?
|
| Acromegaly | 1 | 2013 | 27 | 0.120 |
Why?
|
| Cyclin D1 | 4 | 2004 | 576 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 1998 | 400 | 0.110 |
Why?
|
| RNA, Neoplasm | 5 | 1993 | 771 | 0.110 |
Why?
|
| Pleural Effusion | 4 | 1995 | 201 | 0.110 |
Why?
|
| Plasmacytoma | 1 | 1994 | 111 | 0.110 |
Why?
|
| Ovarian Neoplasms | 8 | 2001 | 4638 | 0.110 |
Why?
|
| Retrospective Studies | 18 | 2013 | 37905 | 0.110 |
Why?
|
| Neoplasm Proteins | 8 | 2013 | 3230 | 0.110 |
Why?
|
| Octreotide | 1 | 2013 | 118 | 0.110 |
Why?
|
| Liver | 1 | 2002 | 2961 | 0.100 |
Why?
|
| Tumor Virus Infections | 3 | 1989 | 224 | 0.100 |
Why?
|
| Disease Progression | 5 | 2015 | 6682 | 0.100 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1991 | 47 | 0.100 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 67 | 0.100 |
Why?
|
| RNA, Small Nucleolar | 1 | 2011 | 25 | 0.100 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2013 | 170 | 0.100 |
Why?
|
| Telomerase | 2 | 2008 | 525 | 0.100 |
Why?
|
| Kidney Neoplasms | 6 | 2021 | 3022 | 0.100 |
Why?
|
| Carcinoma, Lobular | 1 | 1995 | 611 | 0.100 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 1993 | 219 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 4849 | 0.100 |
Why?
|
| Survival Rate | 6 | 2011 | 12221 | 0.100 |
Why?
|
| In Situ Hybridization | 2 | 2020 | 1037 | 0.100 |
Why?
|
| Acridine Orange | 3 | 1992 | 10 | 0.100 |
Why?
|
| Antigens, Surface | 4 | 2004 | 295 | 0.090 |
Why?
|
| Mastocytosis, Systemic | 1 | 2011 | 110 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1991 | 171 | 0.090 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 1082 | 0.090 |
Why?
|
| Meningeal Neoplasms | 1 | 2014 | 441 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2011 | 3536 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2010 | 93 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2010 | 6100 | 0.090 |
Why?
|
| Tissue Fixation | 2 | 2007 | 136 | 0.090 |
Why?
|
| AIDS-Related Complex | 1 | 1989 | 13 | 0.090 |
Why?
|
| Abdominal Neoplasms | 3 | 2001 | 231 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 4 | 1994 | 366 | 0.090 |
Why?
|
| Antigens, CD20 | 3 | 2004 | 206 | 0.090 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 91 | 0.080 |
Why?
|
| Cell Count | 2 | 2004 | 508 | 0.080 |
Why?
|
| Tissue Extracts | 1 | 1989 | 48 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 6 | 2000 | 5061 | 0.080 |
Why?
|
| Disease-Free Survival | 6 | 2014 | 10001 | 0.080 |
Why?
|
| Immunomagnetic Separation | 1 | 2008 | 43 | 0.080 |
Why?
|
| ROC Curve | 2 | 2010 | 1183 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 342 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 1995 | 489 | 0.080 |
Why?
|
| Subarachnoid Space | 1 | 2008 | 36 | 0.080 |
Why?
|
| Inclusion Bodies | 2 | 1986 | 76 | 0.080 |
Why?
|
| Parathyroid Neoplasms | 1 | 2010 | 185 | 0.080 |
Why?
|
| CD5 Antigens | 3 | 2004 | 112 | 0.080 |
Why?
|
| Lymphokines | 1 | 1989 | 272 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2012 | 657 | 0.080 |
Why?
|
| Bone Marrow | 7 | 2011 | 2358 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 1993 | 585 | 0.080 |
Why?
|
| Leukemia | 3 | 1991 | 1635 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 769 | 0.080 |
Why?
|
| Blast Crisis | 1 | 2011 | 557 | 0.080 |
Why?
|
| Eosinophilic Granuloma | 2 | 1993 | 13 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2021 | 9244 | 0.080 |
Why?
|
| Encephalitis | 1 | 1989 | 143 | 0.080 |
Why?
|
| Fenretinide | 1 | 2008 | 96 | 0.080 |
Why?
|
| Administration, Intravesical | 3 | 2015 | 162 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 973 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2011 | 4307 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2003 | 6550 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 4 | 2013 | 3976 | 0.080 |
Why?
|
| Prospective Studies | 6 | 2021 | 12873 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2008 | 298 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 566 | 0.070 |
Why?
|
| Papilledema | 1 | 2008 | 85 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 133 | 0.070 |
Why?
|
| Prostatic Neoplasms | 3 | 2010 | 5767 | 0.070 |
Why?
|
| Antigens, CD19 | 3 | 2010 | 577 | 0.070 |
Why?
|
| Transfection | 3 | 2008 | 2944 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 143 | 0.070 |
Why?
|
| DNA Probes | 2 | 2000 | 217 | 0.070 |
Why?
|
| Intracranial Hypertension | 1 | 2008 | 119 | 0.070 |
Why?
|
| Thiazoles | 1 | 2011 | 726 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 3 | 2002 | 1581 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 362 | 0.070 |
Why?
|
| Cystoscopy | 2 | 2015 | 88 | 0.070 |
Why?
|
| Antigens, Neoplasm | 3 | 1998 | 1506 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 384 | 0.070 |
Why?
|
| Uterine Diseases | 1 | 1986 | 40 | 0.070 |
Why?
|
| Hyphae | 1 | 2006 | 44 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2007 | 176 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 2013 | 3203 | 0.070 |
Why?
|
| Dacarbazine | 1 | 2008 | 485 | 0.070 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 42 | 0.070 |
Why?
|
| Cell Nucleolus | 3 | 1998 | 89 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2009 | 14551 | 0.070 |
Why?
|
| Cell Cycle | 3 | 2005 | 2084 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2008 | 1471 | 0.060 |
Why?
|
| Adolescent | 14 | 2008 | 31252 | 0.060 |
Why?
|
| Sickle Cell Trait | 1 | 2005 | 31 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 1146 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2005 | 181 | 0.060 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2013 | 1105 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2008 | 588 | 0.060 |
Why?
|
| Neoplasm Grading | 3 | 2015 | 1742 | 0.060 |
Why?
|
| Cadherins | 2 | 2021 | 660 | 0.060 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2004 | 41 | 0.060 |
Why?
|
| Condylomata Acuminata | 1 | 1984 | 26 | 0.060 |
Why?
|
| Forecasting | 1 | 2007 | 694 | 0.060 |
Why?
|
| Angiomyolipoma | 1 | 1994 | 31 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2003 | 38 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 878 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 1984 | 72 | 0.060 |
Why?
|
| Activin Receptors, Type I | 1 | 2003 | 50 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2011 | 2527 | 0.060 |
Why?
|
| Receptors, Progesterone | 3 | 2013 | 1392 | 0.060 |
Why?
|
| Carcinoma in Situ | 3 | 2015 | 487 | 0.060 |
Why?
|
| Anus Neoplasms | 1 | 1987 | 411 | 0.060 |
Why?
|
| Nucleolus Organizer Region | 2 | 1994 | 17 | 0.060 |
Why?
|
| Tubulin | 1 | 2003 | 169 | 0.060 |
Why?
|
| Blotting, Southern | 3 | 2011 | 406 | 0.060 |
Why?
|
| Carcinoma, Medullary | 1 | 2005 | 248 | 0.060 |
Why?
|
| Mouth Neoplasms | 2 | 1999 | 713 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2003 | 290 | 0.050 |
Why?
|
| Texas | 2 | 2011 | 6311 | 0.050 |
Why?
|
| Antineoplastic Agents | 4 | 2009 | 14289 | 0.050 |
Why?
|
| Interferon-alpha | 2 | 1997 | 889 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 15862 | 0.050 |
Why?
|
| Y Chromosome | 1 | 2002 | 77 | 0.050 |
Why?
|
| Repressor Proteins | 4 | 2013 | 1664 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 3639 | 0.050 |
Why?
|
| False Negative Reactions | 3 | 1997 | 275 | 0.050 |
Why?
|
| Digestive System | 1 | 2002 | 114 | 0.050 |
Why?
|
| Chromatin | 4 | 1998 | 942 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2054 | 0.050 |
Why?
|
| Survival Analysis | 6 | 2021 | 9180 | 0.050 |
Why?
|
| Common Bile Duct | 1 | 2001 | 27 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 545 | 0.050 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2001 | 57 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 1678 | 0.050 |
Why?
|
| Pancreatic Elastase | 1 | 2021 | 34 | 0.050 |
Why?
|
| Apoptosis | 4 | 2011 | 7591 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 1 | 1982 | 276 | 0.050 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2001 | 44 | 0.050 |
Why?
|
| Nuclear Proteins | 4 | 1999 | 3343 | 0.050 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2001 | 70 | 0.050 |
Why?
|
| Keratins | 2 | 2000 | 330 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 4988 | 0.050 |
Why?
|
| Genital Neoplasms, Female | 1 | 1987 | 735 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1980 | 124 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 81 | 0.050 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2001 | 163 | 0.050 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2021 | 134 | 0.050 |
Why?
|
| Nephrosis | 1 | 2000 | 5 | 0.050 |
Why?
|
| Therapeutic Irrigation | 3 | 1995 | 90 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 1021 | 0.050 |
Why?
|
| Body Fluids | 1 | 1980 | 125 | 0.040 |
Why?
|
| Receptor, ErbB-3 | 1 | 1999 | 122 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2015 | 1391 | 0.040 |
Why?
|
| Mice | 6 | 2011 | 34495 | 0.040 |
Why?
|
| Sarcoma, Kaposi | 1 | 2001 | 187 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2000 | 142 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 1688 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 5 | 2005 | 4367 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2000 | 180 | 0.040 |
Why?
|
| Entamoeba | 1 | 1998 | 4 | 0.040 |
Why?
|
| Recurrence | 2 | 2005 | 4758 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 459 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2011 | 3518 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 1994 | 842 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1989 | 234 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 2216 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2002 | 747 | 0.040 |
Why?
|
| Multiple Myeloma | 2 | 2004 | 2138 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 2 | 2008 | 84 | 0.040 |
Why?
|
| Diploidy | 2 | 1987 | 114 | 0.040 |
Why?
|
| Hyperplasia | 2 | 1997 | 557 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2008 | 4078 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2000 | 1385 | 0.040 |
Why?
|
| Logistic Models | 2 | 2010 | 3441 | 0.040 |
Why?
|
| Bone and Bones | 1 | 1980 | 619 | 0.040 |
Why?
|
| Time Factors | 3 | 2005 | 12926 | 0.040 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1997 | 74 | 0.040 |
Why?
|
| Radioimmunotherapy | 1 | 1997 | 119 | 0.040 |
Why?
|
| Animals | 8 | 2011 | 59536 | 0.040 |
Why?
|
| Monosomy | 2 | 1994 | 95 | 0.040 |
Why?
|
| Mediastinum | 1 | 1998 | 268 | 0.040 |
Why?
|
| Lymphatic Metastasis | 4 | 1997 | 4844 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 49 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 1998 | 512 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1989 | 641 | 0.030 |
Why?
|
| Skin | 1 | 2002 | 1259 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 2001 | 493 | 0.030 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1996 | 44 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 575 | 0.030 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1995 | 27 | 0.030 |
Why?
|
| Treatment Outcome | 8 | 2014 | 32848 | 0.030 |
Why?
|
| Mitogens | 2 | 1989 | 75 | 0.030 |
Why?
|
| Smoking | 1 | 2005 | 2440 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 1995 | 53 | 0.030 |
Why?
|
| Macrophages | 2 | 2000 | 1304 | 0.030 |
Why?
|
| Microscopy, Electron | 4 | 2000 | 600 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 2 | 1989 | 120 | 0.030 |
Why?
|
| Neck | 1 | 1998 | 383 | 0.030 |
Why?
|
| Osteomalacia | 1 | 1995 | 36 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 4757 | 0.030 |
Why?
|
| Neoplasms, Mesothelial | 1 | 1994 | 6 | 0.030 |
Why?
|
| Chromosome Disorders | 3 | 1995 | 417 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 1996 | 130 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1995 | 254 | 0.030 |
Why?
|
| Peritoneum | 1 | 1995 | 150 | 0.030 |
Why?
|
| X Chromosome | 1 | 1995 | 339 | 0.030 |
Why?
|
| Gene Amplification | 2 | 2008 | 731 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 1995 | 205 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1994 | 96 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 1997 | 279 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 1999 | 1130 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 1466 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2001 | 1616 | 0.030 |
Why?
|
| Sarcoma | 1 | 1994 | 1725 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1994 | 185 | 0.030 |
Why?
|
| Combined Modality Therapy | 5 | 2003 | 8865 | 0.030 |
Why?
|
| Child | 7 | 1998 | 29154 | 0.030 |
Why?
|
| Centrifugation | 3 | 1994 | 66 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4053 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 1994 | 414 | 0.030 |
Why?
|
| Alleles | 1 | 1998 | 2437 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 7702 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2008 | 2450 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 476 | 0.030 |
Why?
|
| GATA Transcription Factors | 1 | 2011 | 19 | 0.020 |
Why?
|
| Receptors, Antigen | 1 | 1991 | 76 | 0.020 |
Why?
|
| Sex Factors | 3 | 1988 | 2139 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 11965 | 0.020 |
Why?
|
| Mucocele | 1 | 1991 | 22 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2011 | 682 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2003 | 6869 | 0.020 |
Why?
|
| Vincristine | 2 | 2005 | 1511 | 0.020 |
Why?
|
| Urinalysis | 1 | 2011 | 84 | 0.020 |
Why?
|
| Lung | 2 | 2020 | 3151 | 0.020 |
Why?
|
| Femur | 1 | 2011 | 158 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 118 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2010 | 188 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1991 | 144 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1995 | 631 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2010 | 2292 | 0.020 |
Why?
|
| Mitosis | 2 | 1995 | 615 | 0.020 |
Why?
|
| Polyomaviridae | 1 | 1989 | 1 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1994 | 992 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2010 | 164 | 0.020 |
Why?
|
| Immunoassay | 1 | 1990 | 216 | 0.020 |
Why?
|
| Estrogens | 1 | 1993 | 751 | 0.020 |
Why?
|
| Mycobacterium avium Complex | 1 | 1989 | 29 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1989 | 31 | 0.020 |
Why?
|
| Toxoplasmosis | 1 | 1989 | 28 | 0.020 |
Why?
|
| Child, Preschool | 4 | 1998 | 16273 | 0.020 |
Why?
|
| Breast Diseases | 1 | 1991 | 201 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 479 | 0.020 |
Why?
|
| Orbital Neoplasms | 1 | 2011 | 224 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 1989 | 63 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 701 | 0.020 |
Why?
|
| Aurora Kinases | 1 | 2008 | 189 | 0.020 |
Why?
|
| Breast Neoplasms, Male | 1 | 2010 | 229 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 612 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 6150 | 0.020 |
Why?
|
| Mycosis Fungoides | 1 | 1991 | 320 | 0.020 |
Why?
|
| Vacuoles | 2 | 2000 | 51 | 0.020 |
Why?
|
| Age Factors | 3 | 2005 | 5377 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1217 | 0.020 |
Why?
|
| Cyclophosphamide | 2 | 2005 | 3001 | 0.020 |
Why?
|
| Doxorubicin | 2 | 2005 | 3005 | 0.020 |
Why?
|
| Endoscopy | 1 | 2011 | 479 | 0.020 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1990 | 262 | 0.020 |
Why?
|
| Aurora Kinase A | 1 | 2008 | 202 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2009 | 324 | 0.020 |
Why?
|
| Dasatinib | 1 | 2011 | 862 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1988 | 89 | 0.020 |
Why?
|
| Polyploidy | 1 | 1987 | 73 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 980 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2007 | 46 | 0.020 |
Why?
|
| Placebos | 1 | 2008 | 437 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2009 | 411 | 0.020 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2006 | 28 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 694 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 223 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 1869 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 2488 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 542 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 1987 | 253 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 212 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2002 | 4654 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2005 | 3472 | 0.020 |
Why?
|
| Thrombocytopenia | 2 | 2004 | 846 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 208 | 0.020 |
Why?
|
| Sulfisoxazole | 1 | 1985 | 2 | 0.020 |
Why?
|
| Genome | 1 | 2009 | 672 | 0.020 |
Why?
|
| Pneumonia, Lipid | 1 | 1985 | 5 | 0.020 |
Why?
|
| Gene Expression | 2 | 2006 | 3570 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2006 | 218 | 0.020 |
Why?
|
| Postal Service | 1 | 2005 | 17 | 0.020 |
Why?
|
| Remission Induction | 2 | 2003 | 3569 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1987 | 280 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 1985 | 59 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 1988 | 304 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 2283 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1989 | 462 | 0.020 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2004 | 17 | 0.020 |
Why?
|
| Pneumonia, Aspiration | 1 | 1985 | 41 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 3719 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 130 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2007 | 671 | 0.020 |
Why?
|
| Immunotherapy | 2 | 1989 | 3341 | 0.020 |
Why?
|
| PAX5 Transcription Factor | 1 | 2004 | 45 | 0.020 |
Why?
|
| Hematuria | 1 | 2005 | 85 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1994 | 1763 | 0.020 |
Why?
|
| Ascites | 1 | 1985 | 198 | 0.020 |
Why?
|
| Thorax | 2 | 2001 | 213 | 0.020 |
Why?
|
| Central America | 1 | 1984 | 29 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 2 | 1996 | 3981 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 760 | 0.020 |
Why?
|
| Antigens | 1 | 1985 | 292 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 674 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 577 | 0.010 |
Why?
|
| Lipoma | 1 | 1984 | 89 | 0.010 |
Why?
|
| Graft vs Tumor Effect | 1 | 2003 | 139 | 0.010 |
Why?
|
| Silver Staining | 2 | 1994 | 14 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 966 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 418 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2007 | 489 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 5637 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1995 | 3552 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2005 | 864 | 0.010 |
Why?
|
| Cryptococcus | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cysts | 1 | 1984 | 197 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 1382 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1982 | 27 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1994 | 47 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2002 | 39 | 0.010 |
Why?
|
| Phenotype | 2 | 2009 | 6295 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1982 | 128 | 0.010 |
Why?
|
| Endometrium | 1 | 1986 | 470 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2010 | 1589 | 0.010 |
Why?
|
| Drug Contamination | 1 | 1982 | 52 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1982 | 71 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1985 | 247 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2003 | 335 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 6086 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2074 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1987 | 941 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 2 | 1994 | 197 | 0.010 |
Why?
|
| Biomarkers | 1 | 1993 | 5047 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1982 | 257 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 2001 | 56 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 1544 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2001 | 32 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 4109 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2004 | 429 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2002 | 447 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 1985 | 993 | 0.010 |
Why?
|
| Diatrizoate | 1 | 1980 | 12 | 0.010 |
Why?
|
| Ficoll | 1 | 1980 | 6 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 448 | 0.010 |
Why?
|
| Injections | 1 | 2001 | 285 | 0.010 |
Why?
|
| Histiocytes | 1 | 1980 | 94 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1994 | 3869 | 0.010 |
Why?
|
| Necrosis | 2 | 1995 | 580 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2001 | 229 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 1450 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1997 | 2927 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 168 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 598 | 0.010 |
Why?
|
| Rituximab | 1 | 2005 | 1528 | 0.010 |
Why?
|
| Receptor, ErbB-4 | 1 | 1999 | 23 | 0.010 |
Why?
|
| Cisplatin | 1 | 2007 | 2432 | 0.010 |
Why?
|
| Graft Survival | 1 | 2003 | 1062 | 0.010 |
Why?
|
| Photomicrography | 1 | 1999 | 26 | 0.010 |
Why?
|
| Radiography | 2 | 1995 | 1904 | 0.010 |
Why?
|
| Microscopy | 1 | 1980 | 182 | 0.010 |
Why?
|
| Prostate | 1 | 1985 | 1088 | 0.010 |
Why?
|
| Liposomes | 1 | 2001 | 684 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2001 | 471 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 2796 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1982 | 546 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 182 | 0.010 |
Why?
|
| Capillaries | 1 | 1998 | 99 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 235 | 0.010 |
Why?
|
| Cholesterol | 1 | 2001 | 658 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1999 | 699 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 4298 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1989 | 587 | 0.010 |
Why?
|
| Chromosome Banding | 2 | 1988 | 256 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 2843 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 4549 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1997 | 101 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 1375 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 842 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 334 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 305 | 0.010 |
Why?
|
| Radioimmunodetection | 1 | 1995 | 16 | 0.010 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1996 | 72 | 0.010 |
Why?
|
| Mycobacterium | 1 | 1996 | 56 | 0.010 |
Why?
|
| Primary Myelofibrosis | 1 | 2004 | 831 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 1996 | 89 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1995 | 61 | 0.010 |
Why?
|
| Codon | 1 | 1996 | 241 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1995 | 35 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1997 | 875 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1995 | 185 | 0.010 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 1995 | 88 | 0.010 |
Why?
|
| Genomics | 1 | 2006 | 2738 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 2146 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1995 | 195 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2003 | 2238 | 0.010 |
Why?
|
| Minocycline | 1 | 1996 | 182 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 783 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 2594 | 0.010 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1994 | 26 | 0.010 |
Why?
|
| Infant | 2 | 1993 | 13310 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 486 | 0.010 |
Why?
|
| Gynecomastia | 1 | 1993 | 13 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 974 | 0.010 |
Why?
|
| Mesoderm | 1 | 1995 | 404 | 0.010 |
Why?
|
| Point Mutation | 1 | 1996 | 769 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 1994 | 189 | 0.010 |
Why?
|
| Genes, ras | 1 | 1996 | 667 | 0.010 |
Why?
|
| Trisomy | 1 | 1994 | 231 | 0.010 |
Why?
|
| Neutropenia | 1 | 1997 | 968 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 362 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2003 | 2638 | 0.010 |
Why?
|
| Pancreas | 1 | 1996 | 718 | 0.010 |
Why?
|
| Cytokines | 1 | 2001 | 2809 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2000 | 739 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1993 | 445 | 0.010 |
Why?
|
| Reference Values | 1 | 1994 | 1099 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 3890 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1995 | 1546 | 0.010 |
Why?
|
| Angiography | 1 | 1993 | 360 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1992 | 175 | 0.010 |
Why?
|
| Lymphadenitis | 1 | 1991 | 39 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 167 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1990 | 109 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 4917 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 238 | 0.010 |
Why?
|
| Cancer Care Facilities | 1 | 1993 | 884 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1989 | 149 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 6089 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1994 | 1294 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 43 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1988 | 138 | 0.000 |
Why?
|
| Collodion | 1 | 1987 | 16 | 0.000 |
Why?
|
| Paper | 1 | 1987 | 11 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1994 | 2803 | 0.000 |
Why?
|
| Peritoneal Neoplasms | 1 | 1994 | 821 | 0.000 |
Why?
|
| Cell Survival | 1 | 1994 | 3045 | 0.000 |
Why?
|
| Calcinosis | 1 | 1991 | 423 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 568 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1988 | 270 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 5114 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1987 | 104 | 0.000 |
Why?
|
| Mexico | 1 | 1986 | 259 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1987 | 327 | 0.000 |
Why?
|
| Multigene Family | 1 | 1987 | 425 | 0.000 |
Why?
|
| Endometrial Neoplasms | 1 | 1994 | 1341 | 0.000 |
Why?
|
| Mammography | 1 | 1991 | 1010 | 0.000 |
Why?
|
| Abdomen | 1 | 1986 | 332 | 0.000 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 1985 | 82 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1988 | 1225 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 2992 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1987 | 943 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1988 | 1320 | 0.000 |
Why?
|
| Registries | 1 | 1988 | 2170 | 0.000 |
Why?
|
| United States | 1 | 1988 | 15433 | 0.000 |
Why?
|